Aurobindo Pharma


'Aurobindo Pharma' - 15 Video Result(s)

'Aurobindo Pharma' - 265 News Result(s)

  • Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Nifty Unlikely To Fall Below 7,500, Buy TVS Motor: Shahina Mukadam

    Domestic equities have been pressured by events in the international markets, making bulls a bit nervous, says market expert Shahina Mukadam. Stocks like Reliance Industries, ICICI Bank and other banking shares as a whole are contributing to the fall and keeping markets subdued, she added.

  • Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Gets US Nod For Seizures Treatment Drug

    Aurobindo Pharma has received final approval from the US health regulator for its Lacosamide tablets used for treatment of partial-onset seizures in American market.

  • Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma Gets USFDA Nod For Two Drugs

    Aurobindo Pharma on Wednesday said it has received final approval from the US health regulator to manufacture and market generic version of heartburn relief medicine Famotidine tablets.

  • Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma Gets USFDA Nod For Blood Pressure Drug

    Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets.

  • Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug

    Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug

    Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.

  • Finance Ministry Looks To Expedite Clearances To FDI Proposals

    Finance Ministry Looks To Expedite Clearances To FDI Proposals

    Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).

  • Investment Board To Take Up Axis Bank, 13 Other Proposals

    Investment Board To Take Up Axis Bank, 13 Other Proposals

    FIPB, chaired by Economic Affairs Secretary Shaktikanta Das, will also consider the proposal of Aurobindo Pharma, One97 Communications, Advanced Enzyme Technologies and Macmillan Publishers International Ltd.

  • Aurobindo Gets US Nod For Generic Anti-Infective Drug

    Aurobindo Gets US Nod For Generic Anti-Infective Drug

    Drug firm Aurobindo Pharma has received approval from the US health regulator to market Polymyxin B for Injection, an anti-infective drug, in the American market.

  • Aurobindo Gets USFDA Nod For Generic Anti-Infective Drug

    Aurobindo Gets USFDA Nod For Generic Anti-Infective Drug

    The approved product has an estimated market size of $7.6 million for the twelve months ending February 2016, according to IMS, the company said.

  • Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug

    Aurobindo Pharma Gets Final USFDA Nod For Anti-viral Drug

    Aurobindo Pharma has received final approval from the US health regulator to manufacture and market anti-viral Valganciclovir tablets in the American market.

  • Eicher, Aurobindo, Bharti Infratel Make Weak Debut On Nifty

    Eicher, Aurobindo, Bharti Infratel Make Weak Debut On Nifty

    Four stocks - Aurobindo Pharma, Bharti Infratel, Eicher Motors, and Tata Motors' Differential Voting Rights (DVR) - made a weak debut on the benchmark Nifty 50 index on Friday.

  • Aurobindo Pharma Gets US Regulator's Nod for Antibiotic

    Aurobindo Pharma Gets US Regulator's Nod for Antibiotic

    Aurobindo Pharma has received final approval from the US Food and Drug Administration (FDA) to market its generic antibiotic drug Vancomycin Hydrochloride for Injection in the American market.

  • Aurobindo Pharma Gets Final US FDA Nod For Dementia Drug

    Aurobindo Pharma Gets Final US FDA Nod For Dementia Drug

    Drug firm Aurobindo Pharma has received final approval from US FDA to manufacture and market Rivastigmine Tartrate Capsules USP, used for the treatment of dementia disease, in the American market.

  • Aurobindo Pharma Climbs After USFDA Nod For OTC Drug

    Aurobindo Pharma Climbs After USFDA Nod For OTC Drug

    Shares of Aurobindo Pharma surged over 2 per cent today after the firm got final approval from USFDA to manufacture and market its generic Naproxen Sodiumtablets used for treatment of osteoporosis.

  • Aurobindo Pharma Gets US Regulator's Nod for Osteoporosis Drug

    Aurobindo Pharma Gets US Regulator's Nod for Osteoporosis Drug

    Aurobindo Pharma has received final nod from the US Food and Drug Administration (FDA) to manufacture and market its generic Naproxen Sodium tablets used for the treatment of osteoporosis in postmenopausal women.

................................ Advertisement ................................

................................ Advertisement ................................